Centrifuge
Usual
Store at 4 ºC for up to seven days. For longer periods store at -20 ºC.
Tri-iodothyronine (T3) constitutes approximately 5% of the thyroid hormones in serum. T3 is produced by both the thyroid gland and mono-deiodination of Thyroxine.
(T4) in the peripheral tissues. It is primarily transported by carrier proteins: thyroid binding globulin (TBG), albumin and pre-albumin. T3 has greater metabolic activity than T4, has a shorter half-life and less affinity for TBG. Only about 0.5% of T3 circulates freely in the serum and is considered the biologically active fraction. This is FT3, the measurement of which is is useful in the diagnosis of hyperthyroidism. FT3 measurement has practical importance in thyrotoxic patients (T3 toxicosis) who exhibit elevated FT3 levels while maintaining normal FT4 concentrations.
Free T3 plays an important role in maintenance of the euthyroid state and assists in the diagnosis of thyroid dysfunction. Unlike total T3, free T3 is largely unaffected by variations in thyroid hormone-binding protein levels. Euthyroid patients with elevated concentrations of TBG, as in pregnancy, use of oral contraceptives and estrogen therapy exhibit an increase in total T3 concentrations but not FT3. Euthyroid patients with very low levels of TBG exhibit subnormal levels of total T3 while free T3 concentrations remain essentially “normal”.
Patients receiving therapy with biotin (> 5mg/day) should not have samples taken for analysis until at least 8 hours post dose. Any influence that might affect the binding behaviour of the binding proteins can alter the result of the fT3 tests (e.g. drugs, NTIs (Non‑Thyroid‑Illness) or patients suffering from FDH (Familial Dysalbuminemic Hyperthyroxinemia).
FT3 is measured using an electrochemiluminescence sandwich immunoassay. Any influence that might affect the binding behaviour of the binding proteins can alter the result of the fT3 tests (e.g. drugs, NTIs (Non‑Thyroid‑Illness) or patients suffering from FDH (Familial Dysalbuminemic Hyperthyroxinemia). Fractionated or unfractionated heparin may produce artefactual elevation in measured concentrations of free thyroid hormones. In rare cases, interference due to extremely high titers of antibodies to analyte or to analyte‑specific antibodies, streptavidin or ruthenium can occur. Please contact the laboratory for further advice if tests results are not consistent with the patient's medical history, clinical presentation and/or other findings, as further interference studies can be performed.
Adult reference range = 2.6 - 5.7 pmol/L
NEQAS
Copyright UHB Pathology 2018
Protection of Personal Information – Clinical Laboratory Services comply with the Trust Data Protection Policy and have procedures in place to allow the Directorate and it’s employees to comply with the Data Protection Act 1998 and associated best practice and guidance.
University Hospitals Birmingham medical laboratories at Queen Elizabeth Hospital, Heartlands Hospital, Good Hope Hospital and Solihull Hospital are UKAS (United Kingdom Accreditation Service) accredited to the ISO 15189:2012 standard. For a list of accredited tests and other information please visit the UKAS website using the following link: https://www.ukas.com/find-an-organisation/
Tests not appearing on the UKAS Schedule of Accreditation currently remain outside of our scope of accreditation. However, these tests have been validated to the same high standard as accredited tests and are performed by the same trained and competent staff.
For further test information, please visit the test database: http://qehbpathology.uk/test-database
For further information contact Louise Fallon, Quality Manager, 0121 371 5962